Assessment of hepatitis B immunization status after antineoplastic therapy in children with cancer


KARAMAN S., Vural S., Yildirmak Y., Urganci N., Usta M.

ANNALS OF SAUDI MEDICINE, vol.31, no.6, pp.573-576, 2011 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 31 Issue: 6
  • Publication Date: 2011
  • Doi Number: 10.4103/0256-4947.87091
  • Journal Name: ANNALS OF SAUDI MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.573-576
  • Istanbul University Affiliated: No

Abstract

BACKGROUND AND OBJECTIVES: Hepatitis B is a disease that is preventable with vaccination. Antibody levels after vaccination may be affected by suppression of the immune system due to cancer therapy. Children with cancer have a high risk of hepatitis B virus (HBV) infection. We aimed to assess the pretreatment immunization status against HBV infection and the rate of continuity of immunization after therapy in children with cancer.